1. That was an early trial. When they did a randomized placebo-controlled trial, they found no added benefit. So that pretty much settled the controversy.Here's the most current/best data:
IADT, dutasteride, and the AVIAS trial — not the result some would want to hearThere may be sub-groups, possibly yourself, who it works for. But on the average, it did nothing. The changes in your PSA were minor. I'd be reluctant to use terms like "shot up" to describe movement from 0.16 to 0.20 - there are normal variations in PSA, and PSADT is not a constant or even validated for values under 0.2.
The manufacturer doesn't mention these or any uses of Avodart for which it is not FDA approved. You were taking it "off label" so you can't expect to find anything useful on the label.
2. SpaceOAR is usually a waste of money as far as I can tell. It's use with salvage is even more questionable - its only use, if there is any, is to put more space between the rectum and prostate. What would be the point if there is no prostate? Here's my article about
it:
SpaceOAR hydrogel decreases rectal radiation dose, but is it worthwhile?3. The benefit of adding ADT with salvage RT seems to depend on a number of factors. Here's an article about
it:
Combining ADT and salvage radiation therapy improves outcomes4. Only if there's a reason to suspect nodes are involved. With your low Gleason score and initial PSA, I wouldn't think so, unless you had enlarged nodes on a CT scan.
5. Here's an article about
hypofractionated salvage radiation. Since then, there's been another clinical trial at USC:
NCT02446366Can salvage radiation therapy be safely and effectively completed in less time?6. There is no evidence to suggest that chemo is useful before mets are evident.
- Allen